CJC-1295/Ipamorelin Mix

The CJC-1295/Ipamorelin blend combines a synthetic GHRH analogue with extended half-life (5.8-8.1 days) and a selective ghrelin receptor agonist for synergistic growth hormone elevation. CJC-1295 directly stimulates the GHRH receptor promoting baseline GH secretion, while ipamorelin acts via the ghrelin receptor — together producing superadditive effects on somatotroph GH output. Research demonstrates dose-dependent increases in plasma GH (2-10 fold) and IGF-1 (1.5-3 fold) with this dual-mechanism approach, enhancing anabolic signaling and metabolic regulation beyond either peptide alone.

10mg